955362-07-9

Upstream product

• 955362-47-7 1-{2-[(4-tert-butoxycarbonylaminophenyl)imino]-3,4-dimethyl-2,3-dihydro-1,3-thiazol-5-yl}ethanone 
• 955362-50-2 1,1-dimethylethyl (4-{[(methylamino)carbonothioyl]amino}phenyl)carbamate 
• 1694-29-7 3-chloropentane-2,4-dione 

Downstream Products

• 1146976-81-9 N-(4-{[5-acetyl-3,4-dimethyl-1,3-thiazol-2(3H)-ylidene]amino}phenyl)acetamide 

Relevant academic research and scientific papers

COMPOUNDS WHICH POTENTIATE AMPA RECEPTOR AND USES THEREOF IN MEDICINE

The invention provides compounds of formula (I) and salts thereof wherein R1, R2, R3, R4 and X are as defined in the description. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed.

COMPOUNDS WHICH POTENTIATE AMPA RECEPTOR AND USES THEREOF IN MEDICINE

Compounds of formula (I), and salts and solvates thereof for use as a medicament are provided: (I) wherein R1, R2, R4, R10, X and Z are defined in the specification. Processes for preparation, pharmaceutical com